MedTrace Logo

Clinical Evaluation of Metal Panel Allergens: Dose Response Study

NCT02615249 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2020-08-25

Study results available
· View outcomes & findings →

Summary

48-hour application of metal allergen patches to test for potential allergic responses.

Conditions

  • Dermatitis, Eczematous

Interventions

BIOLOGICAL

Metal Allergen Epicutaneous Patch

48 hour application of metal allergen patch to diagnose contact dermatitis

Sponsors & Collaborators

  • Allerderm

    lead INDUSTRY

Principal Investigators

  • Patricia L Norris, MD · Oregon Health & Science University, Portland USA

  • Karin Pacheco, MD · National Jewish Health School of Medicine, Colorado USA

  • Andreas Bircher, MD · University Hospital, Basel, Switzerland

  • Paolo Pigatto, MD · University of Milano, Italy

  • Thomas Rustemeyer, MD, PhD · VU University Medical Center, Netherlands

  • Peter Thomas, MD · Ludwig-Maximilians-Universität München, Germany

  • Maki Hosoki, DDS, PhD · Tokushima University Graduate School, Japan

  • Risa Tamagawa-Mineoka, MD · Kyoto Prefectural University of Medicine, Japan

  • Akiko Yagami, MD, PhD · Fujita Health University School of Medicine, Japan

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-05
Primary Completion
2019-07-15
Completion
2019-07-15
FDA Drug
Yes

Countries

  • United States
  • Germany
  • Italy
  • Japan
  • Netherlands
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02615249 on ClinicalTrials.gov